Patents Expiring in December 2043

« Back to Dashboard

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use
Biofrontera	AMELUZ	aminolevulinic acid hydrochloride	GEL;TOPICAL	208081-001	May 10, 2016		RX	Yes	Yes			Y
Ani Pharms	PURIFIED CORTROPHIN GEL	corticotropin	INJECTABLE;INJECTION	008975-001	Approved Prior to Jan 1, 1982		DISCN	No	No						IRIDOCYCLITIS
Ani Pharms	PURIFIED CORTROPHIN GEL	corticotropin	INJECTABLE;INJECTION	008975-001	Approved Prior to Jan 1, 1982		DISCN	No	No						IRITIS
Ani Pharms	PURIFIED CORTROPHIN GEL	corticotropin	INJECTABLE;INJECTION	008975-001	Approved Prior to Jan 1, 1982		DISCN	No	No						KERATITIS
Ani Pharms	PURIFIED CORTROPHIN GEL	corticotropin	INJECTABLE;INJECTION	008975-001	Approved Prior to Jan 1, 1982		DISCN	No	No						OPTIC NEURITIS
Ani Pharms	PURIFIED CORTROPHIN GEL	corticotropin	INJECTABLE;INJECTION	008975-001	Approved Prior to Jan 1, 1982		DISCN	No	No						SERUM SICKNESS
Ani Pharms	PURIFIED CORTROPHIN GEL	corticotropin	INJECTABLE;INJECTION	008975-001	Approved Prior to Jan 1, 1982		DISCN	No	No						SEVERE ACUTE AND CHRONIC ALLERGIC AND INFLAMMATORY PROCESSES INVOLVING THE EYE AND ITS ADNEXA